| Name | Kinney Drugs # 94 |
|---|---|
| Organization Name | Kph Healthcare Services Inc |
| Location | 407 Broad St, Lyndonville, Vermont 05851 |
| Type | Community/Retail Pharmacy |
| Phone | (802) 626-3779 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
Some editorials and opinion pieces respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.
As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.
Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.
› Verified 6 days ago
| NPI Number | 1215135702 |
| Organization Name | KPH HEALTHCARE SERVICES, INC. |
| Doing Business As | KINNEY DRUGS #94 |
| Type | Community/Retail Pharmacy |
| Address | 407 Broad St, Lyndonville, VT 05851 |
| Phone Number | 802-626-3779 |
News Archive
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
Some editorials and opinion pieces respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.
As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.
Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.
› Verified 6 days ago
News Archive
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.
Some editorials and opinion pieces respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.
As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.
Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE.
› Verified 6 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 602 Main Street, Lyndonville, Vermont 05819 Phone: (802) 626-0321 | |
Walgreens #17625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 412 Broad St, Lyndonville, Vermont 05851 Phone: (802) 626-4366 | |
Kinney Drugs # 94 Type: Community/Retail Pharmacy Location: 407 Broad St, Lyndonville, Vermont 05851 Phone: (802) 626-3779 |